• 应用纪要

Busiperone

Busiperone

  • Waters Corporation
Mental health issue; mental illness

This is an Application Brief and does not contain a detailed Experimental section.

Abstract

This application brief demonstrates analysis busiperone.

Introduction

The compound analyzed in this study is busiperone (USP Tailing Factors - 1.08).

Experimental

HPLC Method

Column:

Symmetry Shield RP18, 4.6 x 150 mm, 5 μm

Part number:

186000109

Mobile phase:

20 mM phosphate buffer, pH 7.0/acetonitrile 55:45

Flow rate:

1.0 mL/min

Injection volume:

5 μL

Detection:

UV @ 240 nm

Results and Discussion

Featured Products

WA31763.44, June 2003

返回顶部 返回顶部